Request Sample
Request Methodology
Description
The Global Facial Injectables Market valued US 20,159.7 Mn in 2021 and is poised to grow with a CAGR of 25.4% over 2022-2028. Facial injectables are used to improve the physical look of the skin in specific areas of the face. Collagen, hyaluronic acid, and calcium hydroxylapatite are commonly used in these injectables to help restore skin suppleness. They’re utilised to smooth wrinkles, plump lips, improve shallow contours, and lift depressed scars. Face injectables are currently gaining popularity around the world since they are safe, cost-effective, and require little downtime. The skin becomes more prone to wrinkles and sagging as collagen production and fat development under the skin declines with age. This, together with the expanding senior population and the desire to maintain a youthful and healthy appearance, is one of the primary drivers of market expansion. Aside from that, the rising demand for minimally invasive surgeries, as well as the growing trend of medical and cosmetic tourism, are driving market expansion. Furthermore, because too much sun exposure causes skin tissue degradation, the demand for face injectables is rising among extroverted people. In addition, rising disposable incomes, the expanding influence of social media, and the growing number of professional practitioners and users eager to explore organic and biodegradable products are all positive influences on the industry. Aside from that, the leading companies are also delivering customised face injectables to provide users with a more personalised experience, which is expected to boost the market in the approaching years. Some of the key factors impelling the market growth include preference for minimally invasive procedures, increase in pool of geriatric population, rising aesthetic consciousness and number of cosmetic procedures, rise in accidents and obesity, increased safety margins offered by advanced treatments, and the introduction of cost-effective facial injectables. However, side-effects of available products and lack of reimbursement policies supporting cosmetic procedures are hampering the market growth. Further, high growth in emerging economies provides huge growth opportunities for market growth. The global facial injectables market is surging owing to strategic alliances by key players for facial injectables to meet the demands of the customers in the market. For instance, In April 2019, Allergan plc. launched Juvederm VOLUX at the 17th Aesthetic & Anti-Aging World Congress (AMWC) in Monaco. Juvederm VOLUX is the latest innovation in Allergan’s extensive range of Juvederm facial fillers.
